The following set of maps shows the percent of the population fully vaccinated by different outcomes and variables. Case rate per 100,000 population shows a county-level view of COVID-19 vaccination coverage and the number of COVID-19 cases for every 100,000 people over the last 7 days Social Vulnerability Index shows […]
Pfizer, Moderna mRNA vaccines are effective even without post-shot symptoms or prior infection, Johns Hopkins study finds When the two messenger RNA vaccines for COVID-19 first became readily available, many people were talking about side effects—everything from headaches to chills to feeling exhausted for a couple days. Yet plenty of […]
Israelis who had an infection were more protected against the Delta coronavirus variant than those who had an already highly effective COVID-19 vaccine. The natural immune protection that develops after a SARS-CoV-2 infection offers considerably more of a shield against the Delta variant of the pandemic coronavirus than two doses […]
(Reuters Health) – Patients with rheumatic and musculoskeletal diseases may be less likely to mount an antibody response to the Johnson and Johnson (J&J) COVID-19 vaccine compared with those who get an mRNA-based vaccine, a new study suggests. Data from a prospective cohort of 1,039 patients with rheumatic and musculoskeletal […]
The natural immune protection that develops after a SARS-CoV-2 infection offers considerably more of a shield against the Delta variant of the pandemic coronavirus than two doses of the Pfizer-BioNTech vaccine, according to a large Israeli study that some scientists wish came with a “Don’t try this at home” label. […]
UPDATE Getting vaccinated prevents severe illness, hospitalizations, and death. Unvaccinated people should get vaccinated and continue masking until they are fully vaccinated. With the Delta variant, this is more urgent than ever. CDC has updated guidance for fully vaccinated people based on new evidence on the Delta variant. Your COVID-19 Vaccine COVID-19 […]
In a U.K. observational study, two doses of the Pfizer-BioNTech and Oxford/AstraZeneca vaccines had 88% and 67% effectiveness, respectively, against the Delta variant. As the Delta (B.1.617.2) SARS-CoV-2 variant fuels a global surge in COVID-19, an urgent clinical question concerns how effective the available vaccines are against this variant. Using […]
Beyond the obvious advantage for the needle-phobic, the seven intranasal COVID-19 vaccines in development could offer two additional layers of protection against SARS-CoV-2 infection, experts say. First, intranasal vaccines could produce antibodies and attract other components of the immune system to the nose and upper respiratory tract, forming a first […]
This site provides a county-level view of COVID-19 vaccination coverage and social vulnerability measured by CDC Social Vulnerability Index (SVI), which uses U.S. Census data on categories like poverty, housing, and vehicle access to estimate a community’s ability to respond to and recover from disasters or disease outbreaks. The footnotes describe […]
Abstract Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca’s ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive […]
